UNSPSC 85494202: Supplement tricuspid valve with synthetic substitute, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement tricuspid valve with synthetic substitute, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 02UJ3JZ

UNSPSC 85494202 Supplement tricuspid valve with synthetic substitute, percutaneous approach is a Commodity code that shows minimal alignment with recent state and local procurement activity. The code nominally describes a specific cardiac implant procedure, but the recent opportunities tagged under it instead reflect broad healthcare services procurement — occupational medical surveillance, disability medical evaluations, surgical benefit carve-outs, pharmacy benefit management, emergency medical services for youth in custody, and temporary clinical staffing — none of which involve tricuspid valve implants or cardiac device procurement. The mismatch suggests either tagging error or code misapplication within the source jurisdictions' procurement systems.

Issuing bodies posting under this code span state health and transportation departments, county commissioners offices, county health systems, and municipal retirement boards across Arizona, California, Florida, and Washington. Representative recent opportunities include the City of Phoenix Retirement Office's RFP for independent medical evaluation services (due October 16, 2026, $750,000 over five years), the Washington State Department of Transportation's RFP for occupational medical surveillance services for ferry employees across 14 Washington locations (due October 9, 2026), the County of Santa Clara Health System's non-exclusive multiple-award vendor pool for temporary ancillary clinical staffing (due October 7, 2026), and Collier County's RFP for pharmacy benefit management services ($8.7 million annual historical spend, effective January 1, 2026 through December 31, 2028). The code shows no recent activity directly aligned to cardiac devices, implants, or procedure-specific procurement.